IL111963A0 - Platelet activating factor antagonists: imidazopyridine indoles - Google Patents
Platelet activating factor antagonists: imidazopyridine indolesInfo
- Publication number
- IL111963A0 IL111963A0 IL11196394A IL11196394A IL111963A0 IL 111963 A0 IL111963 A0 IL 111963A0 IL 11196394 A IL11196394 A IL 11196394A IL 11196394 A IL11196394 A IL 11196394A IL 111963 A0 IL111963 A0 IL 111963A0
- Authority
- IL
- Israel
- Prior art keywords
- imidazopyridine
- indoles
- activating factor
- platelet activating
- paf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16856493A | 1993-12-16 | 1993-12-16 | |
US32463194A | 1994-10-18 | 1994-10-18 | |
US08/347,528 US5486525A (en) | 1993-12-16 | 1994-12-05 | Platelet activating factor antagonists: imidazopyridine indoles |
Publications (1)
Publication Number | Publication Date |
---|---|
IL111963A0 true IL111963A0 (en) | 1995-03-15 |
Family
ID=27389538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11196394A IL111963A0 (en) | 1993-12-16 | 1994-12-12 | Platelet activating factor antagonists: imidazopyridine indoles |
Country Status (13)
Country | Link |
---|---|
US (1) | US5486525A (de) |
EP (1) | EP0734386B1 (de) |
JP (1) | JPH09507474A (de) |
KR (1) | KR960706494A (de) |
AT (1) | ATE212992T1 (de) |
AU (1) | AU690620B2 (de) |
CA (1) | CA2176247A1 (de) |
DE (1) | DE69429827T2 (de) |
DK (1) | DK0734386T3 (de) |
ES (1) | ES2173171T3 (de) |
IL (1) | IL111963A0 (de) |
PT (1) | PT734386E (de) |
WO (1) | WO1995016687A1 (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2990042B2 (ja) | 1994-06-06 | 1999-12-13 | 吉富製薬株式会社 | 新規縮合環カルボン酸誘導体またはその塩、およびその医薬用途 |
US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
GB9508748D0 (en) * | 1995-04-28 | 1995-06-14 | British Biotech Pharm | Benzimidazole derivatives |
US5633388A (en) * | 1996-03-29 | 1997-05-27 | Viropharma Incorporated | Compounds, compositions and methods for treatment of hepatitis C |
US6630496B1 (en) | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
AU4400597A (en) * | 1996-10-08 | 1998-05-05 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
US5811425A (en) * | 1997-03-04 | 1998-09-22 | Abbott Laboratories | Heterocyclic compounds as COX-2 inhibitors |
US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
TW526202B (en) * | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
US6534535B1 (en) | 1999-08-12 | 2003-03-18 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
AU7962200A (en) * | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
RU2004117907A (ru) * | 2001-11-14 | 2006-01-10 | Шеринг Корпорейшн (US) | Лиганды каннабиноидных рецепторов |
TWI317634B (en) * | 2001-12-13 | 2009-12-01 | Nat Health Research Institutes | Aroyl indoles compounds |
US7528165B2 (en) * | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
US7632955B2 (en) * | 2001-12-13 | 2009-12-15 | National Health Research Institutes | Indole compounds |
CN100503608C (zh) * | 2002-01-07 | 2009-06-24 | 卫材R&D管理株式会社 | 脱氮嘌呤及其用途 |
TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
ATE388937T1 (de) | 2002-06-19 | 2008-03-15 | Schering Corp | Agonisten des cannabinoidrezeptors |
US6906096B2 (en) * | 2002-06-28 | 2005-06-14 | Irm Llc | 4,7-Disubstituted indoles and methods of making |
GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) * | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
JP2007508363A (ja) * | 2003-10-14 | 2007-04-05 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
SE0303180D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
CA2549606C (en) * | 2003-12-22 | 2015-10-06 | K.U. Leuven Research & Development | Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
WO2006033703A1 (en) * | 2004-07-27 | 2006-03-30 | Gilead Sciences, Inc. | Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
CA2592388C (en) * | 2004-12-21 | 2013-04-02 | Steven S. Bondy | Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
US7456289B2 (en) * | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
GB0500604D0 (en) * | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
ATE518860T1 (de) * | 2005-06-22 | 2011-08-15 | Plexxikon Inc | Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren |
CN101370775A (zh) | 2006-01-13 | 2009-02-18 | 惠氏公司 | 作为5-羟基色胺受体配体的经磺酰基取代1h-吲哚 |
CN101454284A (zh) * | 2006-05-26 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
SG175604A1 (en) * | 2006-07-07 | 2011-11-28 | Gilead Sciences Inc | Novel pyridazine compound and use thereof |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
PE20121126A1 (es) * | 2006-12-21 | 2012-08-24 | Plexxikon Inc | Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa |
WO2008079909A1 (en) * | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Pyrrolo [2,3-b] pyridines as kinase modulators |
UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン,インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
TWI404719B (zh) * | 2009-04-03 | 2013-08-11 | Hoffmann La Roche | 組合物及其用途 |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
ES2651296T3 (es) | 2009-10-30 | 2018-01-25 | Janssen Pharmaceutica, N.V. | Derivados de imidazo[1,2-b]piridacina y su uso como inhibidores de PDE10 |
US20110112127A1 (en) | 2009-11-06 | 2011-05-12 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
EP2606031B1 (de) | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Autotaxin-hemmer und anwendungen davon |
EP2672967B1 (de) | 2011-02-07 | 2018-10-17 | Plexxikon Inc. | Verbindungen und verfahren zur kinase-modulation und anzeigen dafür |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
EP2714680B1 (de) | 2011-05-27 | 2015-11-25 | Amira Pharmaceuticals, Inc. | Heterocyclische autotaxin-inhibitoren und ihre verwendungen |
WO2013000924A1 (en) | 2011-06-27 | 2013-01-03 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
RU2657540C2 (ru) | 2012-06-26 | 2018-06-14 | Янссен Фармацевтика Нв | Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств |
BR112015000459B1 (pt) | 2012-07-09 | 2022-02-08 | Janssen Pharmaceutica N.V. | Inibidores da enzima fosfodiesterase 10, seu uso, composição farmacêutica que os compreende, seus processo de preparação e produto |
JP2016145155A (ja) * | 2013-04-30 | 2016-08-12 | 日本農薬株式会社 | フタルアミド誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法 |
GB201321735D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
CA3014554A1 (en) | 2015-06-18 | 2016-12-22 | Cephalon, Inc. | 1,4-substituted piperidine derivative for treating a disorder mediated by fatty acid synthase |
WO2016205590A1 (en) * | 2015-06-18 | 2016-12-22 | Cephalon, Inc. | Substituted 4-benzyl and 4-benzoyl piperidine derivatives |
US10392358B2 (en) * | 2015-09-17 | 2019-08-27 | Micromidas, Inc. | Oxidation chemistry on furan aldehydes |
WO2019195682A1 (en) | 2018-04-05 | 2019-10-10 | Beth Israel Deaconess Medical Center, Inc. | Aryl hydrocarbon receptor modulators and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH574441A5 (de) * | 1973-06-14 | 1976-04-15 | Ciba Geigy Ag | |
DE3200705A1 (de) * | 1982-01-13 | 1983-07-21 | Agfa-Gevaert Ag, 5090 Leverkusen | Farbfotografisches aufzeichnungsmaterial |
PH23498A (en) * | 1984-08-06 | 1989-08-16 | Sterling Drug Inc | 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof |
US5068234A (en) * | 1990-02-26 | 1991-11-26 | Sterling Drug Inc. | 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles |
US5120749A (en) * | 1991-02-20 | 1992-06-09 | Abbott Laboratories | Platelet activating antagonists |
US5459152A (en) * | 1991-07-17 | 1995-10-17 | Abbott Laboratories | Platelet activating factor antagonists |
-
1994
- 1994-12-05 US US08/347,528 patent/US5486525A/en not_active Expired - Fee Related
- 1994-12-08 PT PT95904287T patent/PT734386E/pt unknown
- 1994-12-08 AU AU13036/95A patent/AU690620B2/en not_active Ceased
- 1994-12-08 AT AT95904287T patent/ATE212992T1/de not_active IP Right Cessation
- 1994-12-08 DK DK95904287T patent/DK0734386T3/da active
- 1994-12-08 JP JP7516840A patent/JPH09507474A/ja not_active Withdrawn
- 1994-12-08 DE DE69429827T patent/DE69429827T2/de not_active Expired - Fee Related
- 1994-12-08 ES ES95904287T patent/ES2173171T3/es not_active Expired - Lifetime
- 1994-12-08 CA CA002176247A patent/CA2176247A1/en not_active Abandoned
- 1994-12-08 EP EP95904287A patent/EP0734386B1/de not_active Expired - Lifetime
- 1994-12-08 KR KR1019960703166A patent/KR960706494A/ko not_active Application Discontinuation
- 1994-12-08 WO PCT/US1994/014112 patent/WO1995016687A1/en active IP Right Grant
- 1994-12-12 IL IL11196394A patent/IL111963A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2176247A1 (en) | 1995-06-22 |
KR960706494A (ko) | 1996-12-09 |
AU1303695A (en) | 1995-07-03 |
EP0734386A1 (de) | 1996-10-02 |
ES2173171T3 (es) | 2002-10-16 |
DE69429827T2 (de) | 2002-11-21 |
JPH09507474A (ja) | 1997-07-29 |
AU690620B2 (en) | 1998-04-30 |
ATE212992T1 (de) | 2002-02-15 |
PT734386E (pt) | 2002-07-31 |
DK0734386T3 (da) | 2002-05-27 |
US5486525A (en) | 1996-01-23 |
WO1995016687A1 (en) | 1995-06-22 |
DE69429827D1 (de) | 2002-03-21 |
EP0734386B1 (de) | 2002-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111963A0 (en) | Platelet activating factor antagonists: imidazopyridine indoles | |
IL117723A0 (en) | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists | |
CA2434277A1 (en) | Substituted alkylamine derivatives and methods of use | |
CA2498047A1 (en) | Novel imidazole compounds as transforming growth factor (tgf) inhibitors | |
CA2534571A1 (en) | Substituted isoquinoline derivatives and methods of use | |
CA2401229A1 (en) | Aryl fused azapolycyclic compounds | |
MEP45508A (en) | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof | |
IS7709A (is) | Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar | |
CA2534570A1 (en) | Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use | |
IL161867A (en) | History of 8-pyrazole-xanthine, a process for making them and pharmaceutical preparations containing them | |
MXPA05008148A (es) | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf). | |
MY110108A (en) | Imidazolyl or imidazolylalkyl substituted with a four or five membered nitrigen containing heterocyclic ring | |
EP2165708A3 (de) | Neue Pyrazol-Verbindungen als Hemmer des transformierenden Wachstumsfaktors (TGF) | |
NO930498L (no) | Fremgangsmaate for fremstilling av benzimidazolderivater | |
CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
GR3020866T3 (en) | Indolocarbazole derivatives, processes for their preparation and their use | |
CA2264005A1 (en) | Piperazino derivatives as neurokinin antagonists | |
CA2218887A1 (en) | Piperazino derivatives as neurokinin antagonists | |
EP0595924A4 (en) | Platelet activating factor antagonists | |
CA2436537A1 (en) | Pharmaceutical compositions comprising tiotropium salts and antihistamines | |
CA2423288A1 (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
CA2060333A1 (en) | Use of pyrimido-benzothiazine derivatives |